Literature DB >> 13748804

Physiological disposition of hydralazine (1-hydrazinophthalazine) and a method for its determination in biological fluids.

A R SCHULERT.   

Abstract

Entities:  

Keywords:  BODY FLUIDS/chemistry; HYDRAZINES/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13748804

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  10 in total

1.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  Effects of hydralazine on the elasticity of collagen.

Authors:  H P Kraemer; T Nemetschek; F Gross
Journal:  Experientia       Date:  1979-04-15

3.  Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.

Authors:  J W Jennne
Journal:  J Clin Invest       Date:  1965-12       Impact factor: 14.808

Review 4.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Autoradiographic study of the distribution of [3H]- and [14C]-hydrallazine in the rat.

Authors:  J R Baker; G R Bullock; I H Williamson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

6.  Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

7.  Identification of hydrallazine and hydrallazine hydrazone metabolites in human body fluids and quantitative in vitro comparisons of their smooth muscle relaxant activity.

Authors:  K D Haegele; A J McLean; P du Souich; K Barron; J Laquer; J L McNay; O Carrier
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

8.  Hydralazine-induced lupus: is there a toxic metabolic pathway?

Authors:  J A Timbrell; V Facchini; S J Harland; R Mansilla-Tinoco
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Effect of food on the absorption of hydralazine in man.

Authors:  R J Walden; R Hernandez; D Witts; B R Graham; B N Prichard
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.